Inga Hegemann
Impact in
- Hematology top 2%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Erythropoietin and Anemia Treatment
- Biochemistry top 2%
- Blood transfusion and management
Papers in
- Hematology 18
- Hemophilia Treatment and Research 13
- Iron Metabolism and Disorders 3
- Chronic Myeloid Leukemia Treatments 3
- Genetics 7
- Hemoglobinopathies and Related Disorders 4
- Co-authors
- Donat Rudolf Spahn (3 shared papers)Burkhardt Seifert (2 shared papers)Felix Schoenrath (2 shared papers)Alexander Kaserer (2 shared papers)Volkmar Falk (2 shared papers)Gabriela H. Spahn (2 shared papers)Francesco Maisano (1 shared paper)Philipp Stein (1 shared paper)
- Journals
- Swiss Medical Weekly (5 papers)Blood (2 papers)British Journal of Haematology (2 papers)Research and Practice in Thrombosis and Haemostasis (2 papers)Blood Advances (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Inga Hegemann
29 papers receiving 974 citations
Peers
Comparison fields: 5 of 60
- Hematology 464
- Biochemistry 215
- Internal Medicine 67
- Genetics 141
- Critical Care and Intensive Care Medicine 62
Countries citing papers authored by Inga Hegemann
This map shows the geographic impact of Inga Hegemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Hegemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Hegemann more than expected).
Fields of papers citing papers by Inga Hegemann
This network shows the impact of papers produced by Inga Hegemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Hegemann. The network helps show where Inga Hegemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Inga Hegemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 306 | |
| 2 | 2019 | 283 | |
| 3 | 2020 | 78 | |
| 4 | 2022 | 35 | |
| 5 | 2021 | 32 | |
| 6 | 2018 | 29 | |
| 7 | 2023 | 25 | |
| 8 | 2021 | 22 | |
| 9 | 2016 | 22 | |
| 10 | 2021 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2016 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 15 | |
| 17 | 2019 | 15 | |
| 18 | 2024 | 10 | |
| 19 | 2010 | 10 | |
| 20 | 2023 | 8 |
About Inga Hegemann
Inga Hegemann is a scholar working on Hematology, Genetics, Internal Medicine, Biochemistry and Physiology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (13 papers), Erythrocyte Function and Pathophysiology (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Blood transfusion and management (3 papers), Iron Metabolism and Disorders (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Hematology (464 citations), Biochemistry (215 citations), Internal Medicine (67 citations), Genetics (141 citations) and Critical Care and Intensive Care Medicine (62 citations). Inga Hegemann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Donat Rudolf Spahn, Burkhardt Seifert, Felix Schoenrath, Alexander Kaserer, Volkmar Falk, Gabriela H. Spahn, Francesco Maisano, Philipp Stein, Oliver Michel Theusinger and Axel Hofmann. Their work appears in journals such as Swiss Medical Weekly, Blood, British Journal of Haematology, Research and Practice in Thrombosis and Haemostasis and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.